ENTRY       2100              CDS       T01001
NAME        ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2
DEFINITION  (RefSeq) estrogen receptor 2
ORTHOLOGY   K08551  estrogen receptor beta
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01522  Endocrine resistance
            hsa04915  Estrogen signaling pathway
            hsa04917  Prolactin signaling pathway
            hsa05224  Breast cancer
DRUG_TARGET Acolbifene hydrochloride: D02758
            Afimoxifene: D06551
            Arzoxifene hydrochloride: D02993
            Bazedoxifene: D03062
            Clometherone: D03551
            Clomifene (DG00474): D00962 D07726
            Conjugated estrogens (DG00465): D04070 D05987
            Delmadinone acetate: D03675
            Dienestrol: D00898
            Diethylstilbestrol (DG00466): D00577 D00946 D07826
            Droloxifene (DG01265): D03911 D03912
            Epitiostanol: D01265
            Equilin: D04041
            Erteberel: D09899
            Estradiol (DG00462): D00105 D01413 D01617 D01953 D04061 D04063 D04064 D04065 D07918 D07919
            Estriol (DG00463): D00185 D01986 D01989 D07920 D07921
            Estrogens, esterified: D04071
            Estrone (DG00464): D00067 D00312 D00948
            Ethinylestradiol (DG00461): D00554 D07928
            Fispemifene: D10008
            Fulvestrant: D01161
            Hexestrol: D01641
            Hexestrol diacetate: D02018
            Idoxifene: D04496
            Lasofoxifene: D04672
            Levormeloxifene fumarate: D09834
            Mepitiostane: D01602
            Mestranol: D00575
            Miproxifene phosphate: D01853
            Nafoxidine hydrochloride: D05106
            Nitromifene citrate: D05192
            Ormeloxifen: D08301
            Ospemifene: D08958
            Polyestradiol phosphate: D07434
            Prinaberel: D06631
            Promestriene: D07221
            Raloxifene (DG00476): D02217 D08465 D10606
            Tamoxifen (DG00734): D00966 D08559
            Tibolone: D01639
            Toremifene (DG00735): D00967 D08620
            Trioxifene mesylate: D06245
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Organismal Systems
              Endocrine system
               04915 Estrogen signaling pathway
                2100 (ESR2)
               04917 Prolactin signaling pathway
                2100 (ESR2)
             Human Diseases
              Cancers
               05224 Breast cancer
                2100 (ESR2)
              Drug resistance
               01522 Endocrine resistance
                2100 (ESR2)
            Transcription factors [BR:hsa03000]
             Eukaryotic Type
              Zinc finger
               Cys4 estrogen-like
                2100 (ESR2)
            Nuclear receptors [BR:hsa03310]
             3. Estrogen like
              3A. Estrogen receptor
               2100 (ESR2)
POSITION    14q23.2-q23.3
MOTIF       Pfam: ERbeta_N Hormone_recep zf-C4
DBLINKS     NCBI-GeneID: 2100
            NCBI-ProteinID: NP_001428
            OMIM: 601663
            HGNC: 3468
            Ensembl: ENSG00000140009
            Vega: OTTHUMG00000141306
            Pharos: Q92731(Tclin)
            UniProt: Q92731 Q7LCB3
STRUCTURE   PDB: 3OLL 2YJD 3OMQ 1YYE 3OMP 4ZI1 4J24 2NV7 3OLS 2GIU 2FSZ
                 1ZAF 1X76 3OMO 1U3R 2JJ3 4J26 1X7J 1X78 1X7B 2Z4B 1U9E
                 1U3Q 5TOA 2I0G 1U3S 2QTU 1YY4 1L2J 1NDE 2YLY 1QKM
AASEQ       530
            MDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYSPAVMNYSIPS
            NVTNLEGGPGRQTTSPNVLWPTPGHLSPLVVHRQLSHLYAEPQKSPWCEARSLEHTLPVN
            RETLKRKVSGNRCASPVTGPGSKRDAHFCAVCSDYASGYHYGVWSCEGCKAFFKRSIQGH
            NDYICPATNQCTIDKNRRKSCQACRLRKCYEVGMVKCGSRRERCGYRLVRRQRSADEQLH
            CAGKAKRSGGHAPRVRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTK
            LADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDL
            VLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDA
            DSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMK
            CKNVVPVYDLLLEMLNAHVLRGCKSSITGSECSPAEDSKSKEGSQNPQSQ
NTSEQ       1593
            atggatataaaaaactcaccatctagccttaattctccttcctcctacaactgcagtcaa
            tccatcttacccctggagcacggctccatatacataccttcctcctatgtagacagccac
            catgaatatccagccatgacattctatagccctgctgtgatgaattacagcattcccagc
            aatgtcactaacttggaaggtgggcctggtcggcagaccacaagcccaaatgtgttgtgg
            ccaacacctgggcacctttctcctttagtggtccatcgccagttatcacatctgtatgcg
            gaacctcaaaagagtccctggtgtgaagcaagatcgctagaacacaccttacctgtaaac
            agagagacactgaaaaggaaggttagtgggaaccgttgcgccagccctgttactggtcca
            ggttcaaagagggatgctcacttctgcgctgtctgcagcgattacgcatcgggatatcac
            tatggagtctggtcgtgtgaaggatgtaaggccttttttaaaagaagcattcaaggacat
            aatgattatatttgtccagctacaaatcagtgtacaatcgataaaaaccggcgcaagagc
            tgccaggcctgccgacttcggaagtgttacgaagtgggaatggtgaagtgtggctcccgg
            agagagagatgtgggtaccgccttgtgcggagacagagaagtgccgacgagcagctgcac
            tgtgccggcaaggccaagagaagtggcggccacgcgccccgagtgcgggagctgctgctg
            gacgccctgagccccgagcagctagtgctcaccctcctggaggctgagccgccccatgtg
            ctgatcagccgccccagtgcgcccttcaccgaggcctccatgatgatgtccctgaccaag
            ttggccgacaaggagttggtacacatgatcagctgggccaagaagattcccggctttgtg
            gagctcagcctgttcgaccaagtgcggctcttggagagctgttggatggaggtgttaatg
            atggggctgatgtggcgctcaattgaccaccccggcaagctcatctttgctccagatctt
            gttctggacagggatgaggggaaatgcgtagaaggaattctggaaatctttgacatgctc
            ctggcaactacttcaaggtttcgagagttaaaactccaacacaaagaatatctctgtgtc
            aaggccatgatcctgctcaattccagtatgtaccctctggtcacagcgacccaggatgct
            gacagcagccggaagctggctcacttgctgaacgccgtgaccgatgctttggtttgggtg
            attgccaagagcggcatctcctcccagcagcaatccatgcgcctggctaacctcctgatg
            ctcctgtcccacgtcaggcatgcgagtaacaagggcatggaacatctgctcaacatgaag
            tgcaaaaatgtggtcccagtgtatgacctgctgctggagatgctgaatgcccacgtgctt
            cgcgggtgcaagtcctccatcacggggtccgagtgcagcccggcagaggacagtaaaagc
            aaagagggctcccagaacccacagtctcagtga
///
